摘要 |
<p>The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering N-{3-Chloro-4-[(3- fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4- quinazolinamine, or a pharmaceutically acceptable hydrate and/or salt thereof, and 2,4-difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3- pyridinyl}benzenesulfonamide, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt thereof, to a human in need thereof.</p> |
申请人 |
GLAXOSMITHKLINE LLC;GREGER, JAMES, G.;LIU, LI;GILMER, TONA, M. |
发明人 |
GREGER, JAMES, G.;LIU, LI;GILMER, TONA, M. |